Literature DB >> 19156243

TandemHeart insertion via a femoral arterial GORE-TEX graft conduit in a high-risk patient.

Jonas Busch1, Guillermo Torre-Amione, George P Noon, Matthias Loebe.   

Abstract

The TandemHeart percutaneous ventricular assist device (pVAD), which provides temporary circulatory support of the left ventricle, can be used in high-risk and hemodynamically unstable patients. The easily inserted TandemHeart provides cardiac support superior to that from the use of intra-aortic balloon pumps. Herein, we discuss TandemHeart implantation via end-to-side femoral arterial grafting in a cardiac patient whose sepsis and multiorgan failure were complicated by coagulopathy and thromboembolism. A 47-year-old woman, on intra-aortic balloon and intravenous inotropic support after an acute myocardial infarction and emergency coronary artery bypass grafting, was transferred to our institution via helicopter. She developed sepsis and multiorgan failure. Her condition was further complicated by coagulopathy and a left-lower-extremity thromboembolism. After 6 weeks of aggressive pharmacologic and intermittent intra-aortic balloon treatment, the patient developed cardiogenic shock and received a TandemHeart pVAD for short-term circulatory support. A GORE-TEX access graft, sewn end-to-side to the femoral artery because of the patient's leg ischemia and very small vessels, served as a conduit for the TandemHeart's femoral arterial inflow cannula. Her difficult circulatory, anatomic, and coagulopathic status stabilized after 2 weeks of TandemHeart support, and she was bridged to the long-term MicroMed DeBakey VAD Child in anticipation of heart transplantation. The case of our patient shows that high-risk patients who have experienced cardiogenic shock with multiorgan failure and coagulopathy can benefit from the TandemHeart pVAD as a bridge to other therapeutic options, even when creative approaches to treatment and to TandemHeart insertion are required.

Entities:  

Keywords:  Cardiac output, low/therapy; equipment design; heart failure/surgery/therapy; heart valve prosthesis implantation/methods; heart-assist devices; patient selection; risk factors; shock, cardiogenic/therapy; treatment outcome; ventricular dysfunction, left/therapy

Mesh:

Substances:

Year:  2008        PMID: 19156243      PMCID: PMC2607081     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  10 in total

1.  Clinical experience with the TandemHeart percutaneous ventricular assist device.

Authors:  Biswajit Kar; Lindsay E Adkins; Andrew B Civitello; Pranav Loyalka; Nanthini Palanichamy; Courtney J Gemmato; Timothy J Myers; Igor D Gregoric; Reynolds M Delgado
Journal:  Tex Heart Inst J       Date:  2006

2.  Temporary support with Tandemheart pVAD during percutaneous aortic valve replacement in an animal model: rationale and methodology.

Authors:  Biswajit Kar; Reynolds M Delgado; Andrew B Civitello; Pranav Loyalka; David Paniagua; R David Fish; Matthew D Forrester; Daniel Moser; Branislav Radovancevic
Journal:  Tex Heart Inst J       Date:  2005

3.  First use of the TandemHeart percutaneous left ventricular assist device as a short-term bridge to cardiac transplantation.

Authors:  Saverio La Francesca; Nanthini Palanichamy; Biswajit Kar; Igor D Gregoric
Journal:  Tex Heart Inst J       Date:  2006

4.  Feasibility study of the use of the TandemHeart percutaneous ventricular assist device for treatment of cardiogenic shock.

Authors:  Daniel Burkhoff; William O'Neill; Corinna Brunckhorst; Dustin Letts; David Lasorda; Howard A Cohen
Journal:  Catheter Cardiovasc Interv       Date:  2006-08       Impact factor: 2.692

5.  Initial report of percutaneous right ventricular assist for right ventricular shock secondary to right ventricular infarction.

Authors:  Gregory M Giesler; Jaime S Gomez; George Letsou; Mary Vooletich; Richard W Smalling
Journal:  Catheter Cardiovasc Interv       Date:  2006-08       Impact factor: 2.692

Review 6.  Implantable left ventricular assist devices.

Authors:  D J Goldstein; M C Oz; E A Rose
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

Review 7.  Percutaneous left ventricular support devices.

Authors:  Michael S Lee; Raj R Makkar
Journal:  Cardiol Clin       Date:  2006-05       Impact factor: 2.213

8.  A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock.

Authors:  Daniel Burkhoff; Howard Cohen; Corinna Brunckhorst; William W O'Neill
Journal:  Am Heart J       Date:  2006-09       Impact factor: 4.749

Review 9.  Left ventricular assist devices as destination therapy.

Authors:  Virginia Fidrocki Mason; Annette Jakubisin Konicki
Journal:  AACN Clin Issues       Date:  2003-11

Review 10.  The role of bridge to transplantation: should LVAD patients be transplanted?

Authors:  Emma J Birks; Magdi H Yacoub; Nicholas R Banner; Asghar Khaghani
Journal:  Curr Opin Cardiol       Date:  2004-03       Impact factor: 2.161

  10 in total
  1 in total

1.  Modified T-Graft for Extracorporeal Membrane Oxygenation in a Patient with Small-Caliber Femoral Arteries.

Authors:  Daniel Calderon; Aly El-Banayosy; Michael M Koerner; Amy B Reed; Faisal Aziz
Journal:  Tex Heart Inst J       Date:  2015-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.